Global Sustained Release Ocular Drug Delivery Systems Sales Market Report 2018

持続放出眼内薬物送達システムの世界市場2018

◆タイトル:Global Sustained Release Ocular Drug Delivery Systems Sales Market Report 2018
◆商品コード:QYR8056337
◆調査・発行会社:QYResearch
◆発行日:2018年4月
◆ページ数:114
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:Pharma & Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Enterprise(同一法人内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、持続放出眼内薬物送達システムの世界市場について調査・分析し、持続放出眼内薬物送達システムのメーカー別販売量、市場シェア分析、種類別販売分析(リポソーム、マイクロカプセル/ナノカプセル、ミクロスフェア/ナノスフェア、インプラント)、用途別販売分析(白内障、緑内障、角膜移植、その他)、地域別販売分析(米国、中国、欧州、日本、東南アジア、インド)、価格動向、企業動向、持続放出眼内薬物送達システム産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・持続放出眼内薬物送達システム市場概要
・持続放出眼内薬物送達システムのメーカー別販売量・メーカー別シェア
・持続放出眼内薬物送達システムの世界市場:種類別販売量(リポソーム、マイクロカプセル/ナノカプセル、ミクロスフェア/ナノスフェア、インプラント)
・持続放出眼内薬物送達システムの世界市場:用途別販売量(白内障、緑内障、角膜移植、その他)
・持続放出眼内薬物送達システムの世界市場:地域別販売量・市場シェア
・持続放出眼内薬物送達システムの米国市場規模
・持続放出眼内薬物送達システムの中国市場規模
・持続放出眼内薬物送達システムの欧州市場規模
・持続放出眼内薬物送達システムの日本市場規模
・持続放出眼内薬物送達システムの東南アジア市場規模
・持続放出眼内薬物送達システムのインド市場規模
・持続放出眼内薬物送達システムのメーカー別分析(企業概要、事業概要、製品概要、収益、価格等)
・持続放出眼内薬物送達システムのコスト分析・価格動向
・持続放出眼内薬物送達システムの産業チェーン(サプライチェーン分析)
・持続放出眼内薬物送達システムのマーケティング戦略・販売チャネル、流通業者
・持続放出眼内薬物送達システム市場への影響要因分析
・持続放出眼内薬物送達システムの世界市場予測
・持続放出眼内薬物送達システムの米国市場予測
・持続放出眼内薬物送達システムの中国市場予測
・持続放出眼内薬物送達システムの欧州市場予測
・持続放出眼内薬物送達システムの日本市場予測
・持続放出眼内薬物送達システムの東南アジア市場予測
・持続放出眼内薬物送達システムのインド市場予測
・持続放出眼内薬物送達システムの種類別世界市場予測(リポソーム、マイクロカプセル/ナノカプセル、ミクロスフェア/ナノスフェア、インプラント)
・持続放出眼内薬物送達システムの用途別世界市場予測(白内障、緑内障、角膜移植、その他)
...

In this report, the global Sustained Release Ocular Drug Delivery Systems market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
Geographically, this report split global into several key Regions, with sales (K Pcs), revenue (Million USD), market share and growth rate of Sustained Release Ocular Drug Delivery Systems for these regions, from 2013 to 2025 (forecast), covering
United States
China
Europe
Japan
Southeast Asia
India

Global Sustained Release Ocular Drug Delivery Systems market competition by top manufacturers/players, with Sustained Release Ocular Drug Delivery Systems sales volume, Price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including
pSivida
Allergan
Icon Bioscience
Ocular Therapeutix
Neurotech Pharmaceuticals
Santen Pharmaceutical
Aciont Inc.
Envisia Therapeutics
GrayBug
Innocore Pharmaceuticals
OHR Pharmaceuticals
PolyActiva
TheraKine
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Liposome
Microcapsules/Nanocapsules
Microspheres/Nanosptheres
Implants
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Cataract
Glaucoma
Corneal Transplantation
Others

If you have any special requirements, please let us know and we will offer you the report as you want.

【レポートの目次】

Table of Contents

Global Sustained Release Ocular Drug Delivery Systems Sales Market Report 2018
1 Sustained Release Ocular Drug Delivery Systems Market Overview
1.1 Product Overview and Scope of Sustained Release Ocular Drug Delivery Systems
1.2 Classification of Sustained Release Ocular Drug Delivery Systems by Product Category
1.2.1 Global Sustained Release Ocular Drug Delivery Systems Market Size (Sales) Comparison by Type (2013-2025)
1.2.2 Global Sustained Release Ocular Drug Delivery Systems Market Size (Sales) Market Share by Type (Product Category) in 2017
1.2.3 Liposome
1.2.4 Microcapsules/Nanocapsules
1.2.5 Microspheres/Nanosptheres
1.2.6 Implants
1.3 Global Sustained Release Ocular Drug Delivery Systems Market by Application/End Users
1.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales (Volume) and Market Share Comparison by Application (2013-2025)
1.3.2 Cataract
1.3.3 Glaucoma
1.3.4 Corneal Transplantation
1.3.5 Others
1.4 Global Sustained Release Ocular Drug Delivery Systems Market by Region
1.4.1 Global Sustained Release Ocular Drug Delivery Systems Market Size (Value) Comparison by Region (2013-2025)
1.4.2 United States Sustained Release Ocular Drug Delivery Systems Status and Prospect (2013-2025)
1.4.3 China Sustained Release Ocular Drug Delivery Systems Status and Prospect (2013-2025)
1.4.4 Europe Sustained Release Ocular Drug Delivery Systems Status and Prospect (2013-2025)
1.4.5 Japan Sustained Release Ocular Drug Delivery Systems Status and Prospect (2013-2025)
1.4.6 Southeast Asia Sustained Release Ocular Drug Delivery Systems Status and Prospect (2013-2025)
1.4.7 India Sustained Release Ocular Drug Delivery Systems Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Sustained Release Ocular Drug Delivery Systems (2013-2025)
1.5.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2025)
1.5.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2025)

2 Global Sustained Release Ocular Drug Delivery Systems Competition by Players/Suppliers, Type and Application
2.1 Global Sustained Release Ocular Drug Delivery Systems Market Competition by Players/Suppliers
2.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share of Key Players/Suppliers (2013-2018)
2.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Sustained Release Ocular Drug Delivery Systems (Volume and Value) by Type
2.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Type (2013-2018)
2.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Type (2013-2018)
2.3 Global Sustained Release Ocular Drug Delivery Systems (Volume and Value) by Region
2.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales and Market Share by Region (2013-2018)
2.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Market Share by Region (2013-2018)
2.4 Global Sustained Release Ocular Drug Delivery Systems (Volume) by Application

3 United States Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
3.1 United States Sustained Release Ocular Drug Delivery Systems Sales and Value (2013-2018)
3.1.1 United States Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2018)
3.1.2 United States Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2018)
3.1.3 United States Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2013-2018)
3.2 United States Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players (2013-2018)
3.3 United States Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type (2013-2018)
3.4 United States Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application (2013-2018)

4 China Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
4.1 China Sustained Release Ocular Drug Delivery Systems Sales and Value (2013-2018)
4.1.1 China Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2018)
4.1.2 China Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2018)
4.1.3 China Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2013-2018)
4.2 China Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players (2013-2018)
4.3 China Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type (2013-2018)
4.4 China Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application (2013-2018)

5 Europe Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
5.1 Europe Sustained Release Ocular Drug Delivery Systems Sales and Value (2013-2018)
5.1.1 Europe Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2018)
5.1.2 Europe Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2018)
5.1.3 Europe Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2013-2018)
5.2 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players (2013-2018)
5.3 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type (2013-2018)
5.4 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application (2013-2018)

6 Japan Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
6.1 Japan Sustained Release Ocular Drug Delivery Systems Sales and Value (2013-2018)
6.1.1 Japan Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2018)
6.1.2 Japan Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2018)
6.1.3 Japan Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2013-2018)
6.2 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application (2013-2018)

7 Southeast Asia Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
7.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales and Value (2013-2018)
7.1.1 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2018)
7.1.2 Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2018)
7.1.3 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2013-2018)
7.2 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application (2013-2018)

8 India Sustained Release Ocular Drug Delivery Systems (Volume, Value and Sales Price)
8.1 India Sustained Release Ocular Drug Delivery Systems Sales and Value (2013-2018)
8.1.1 India Sustained Release Ocular Drug Delivery Systems Sales and Growth Rate (2013-2018)
8.1.2 India Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate (2013-2018)
8.1.3 India Sustained Release Ocular Drug Delivery Systems Sales Price Trend (2013-2018)
8.2 India Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Players (2013-2018)
8.3 India Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Type (2013-2018)
8.4 India Sustained Release Ocular Drug Delivery Systems Sales Volume and Market Share by Application (2013-2018)

9 Global Sustained Release Ocular Drug Delivery Systems Players/Suppliers Profiles and Sales Data
9.1 pSivida
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 pSivida Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.1.4 Main Business/Business Overview
9.2 Allergan
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Allergan Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.2.4 Main Business/Business Overview
9.3 Icon Bioscience
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.3.4 Main Business/Business Overview
9.4 Ocular Therapeutix
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.4.4 Main Business/Business Overview
9.5 Neurotech Pharmaceuticals
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.5.4 Main Business/Business Overview
9.6 Santen Pharmaceutical
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.6.4 Main Business/Business Overview
9.7 Aciont Inc.
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.7.4 Main Business/Business Overview
9.8 Envisia Therapeutics
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.8.4 Main Business/Business Overview
9.9 GrayBug
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 GrayBug Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.9.4 Main Business/Business Overview
9.10 Innocore Pharmaceuticals
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Sustained Release Ocular Drug Delivery Systems Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales, Revenue, Price and Gross Margin (2013-2018)
9.10.4 Main Business/Business Overview
9.11 OHR Pharmaceuticals
9.12 PolyActiva
9.13 TheraKine

10 Sustained Release Ocular Drug Delivery Systems Maufacturing Cost Analysis
10.1 Sustained Release Ocular Drug Delivery Systems Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
10.3 Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Sustained Release Ocular Drug Delivery Systems Major Manufacturers in 2017
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Sustained Release Ocular Drug Delivery Systems Market Forecast (2018-2025)
14.1 Global Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Price Forecast (2018-2025)
14.1.1 Global Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate Forecast (2018-2025)
14.1.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2018-2025)
14.1.3 Global Sustained Release Ocular Drug Delivery Systems Price and Trend Forecast (2018-2025)
14.2 Global Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
14.2.1 Global Sustained Release Ocular Drug Delivery Systems Sales Volume and Growth Rate Forecast by Regions (2018-2025)
14.2.2 Global Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast by Regions (2018-2025)
14.2.3 United States Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.4 China Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.5 Europe Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.6 Japan Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.7 Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.2.8 India Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Sustained Release Ocular Drug Delivery Systems Sales Volume, Revenue and Price Forecast by Type (2018-2025)
14.3.1 Global Sustained Release Ocular Drug Delivery Systems Sales Forecast by Type (2018-2025)
14.3.2 Global Sustained Release Ocular Drug Delivery Systems Revenue Forecast by Type (2018-2025)
14.3.3 Global Sustained Release Ocular Drug Delivery Systems Price Forecast by Type (2018-2025)
14.4 Global Sustained Release Ocular Drug Delivery Systems Sales Volume Forecast by Application (2018-2025)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Sustained Release Ocular Drug Delivery Systems
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (Product Category) in 2017
Figure Liposome Product Picture
Figure Microcapsules/Nanocapsules Product Picture
Figure Microspheres/Nanosptheres Product Picture
Figure Implants Product Picture
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application in 2017
Figure Cataract Examples
Table Key Downstream Customer in Cataract
Figure Glaucoma Examples
Table Key Downstream Customer in Glaucoma
Figure Corneal Transplantation Examples
Table Key Downstream Customer in Corneal Transplantation
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Sustained Release Ocular Drug Delivery Systems Market Size (Million USD) by Regions (2013-2025)
Figure United States Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Sustained Release Ocular Drug Delivery Systems Sales Share by Players/Suppliers
Figure 2017 Sustained Release Ocular Drug Delivery Systems Sales Share by Players/Suppliers
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Players
Table 2017 Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Players
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2013-2018)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate by Type (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Type (2013-2018)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate by Type (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Share by Region (2013-2018)
Figure Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Region (2013-2018)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Growth Rate by Region in 2017
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Region (2013-2018)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Growth Rate by Region in 2017
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Sustained Release Ocular Drug Delivery Systems by Region (2013-2018)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share by Region in 2017
Table Global Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Sustained Release Ocular Drug Delivery Systems by Application (2013-2018)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share by Application (2013-2018)
Figure United States Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Players (2013-2018)
Table United States Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players (2013-2018)
Figure United States Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players in 2017
Table United States Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2013-2018)
Table United States Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (2013-2018)
Figure United States Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type in 2017
Table United States Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2013-2018)
Table United States Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application (2013-2018)
Figure United States Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application in 2017
Figure China Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Trend (2013-2018)
Table China Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Players (2013-2018)
Table China Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players (2013-2018)
Figure China Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players in 2017
Table China Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2013-2018)
Table China Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (2013-2018)
Figure China Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type in 2017
Table China Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2013-2018)
Table China Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application (2013-2018)
Figure China Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application in 2017
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players (2013-2018)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players in 2017
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (2013-2018)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type in 2017
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application (2013-2018)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application in 2017
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players (2013-2018)
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players in 2017
Table Japan Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (2013-2018)
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type in 2017
Table Japan Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application (2013-2018)
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application in 2017
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players in 2017
Table Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type in 2017
Table Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application in 2017
Figure India Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Sustained Release Ocular Drug Delivery Systems Sales Price (USD/Pcs) Trend (2013-2018)
Table India Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Players (2013-2018)
Table India Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players (2013-2018)
Figure India Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Players in 2017
Table India Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Type (2013-2018)
Table India Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type (2013-2018)
Figure India Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Type in 2017
Table India Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) by Application (2013-2018)
Table India Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application (2013-2018)
Figure India Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share by Application in 2017
Table pSivida Basic Information List
Table pSivida Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure pSivida Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure pSivida Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure pSivida Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Allergan Basic Information List
Table Allergan Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Allergan Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure Allergan Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Icon Bioscience Basic Information List
Table Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018
Figure Icon Bioscience Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Ocular Therapeutix Basic Information List
Table Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure Ocular Therapeutix Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Neurotech Pharmaceuticals Basic Information List
Table Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure Neurotech Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Santen Pharmaceutical Basic Information List
Table Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018
Figure Santen Pharmaceutical Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Aciont Inc. Basic Information List
Table Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure Aciont Inc. Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Envisia Therapeutics Basic Information List
Table Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018
Figure Envisia Therapeutics Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table GrayBug Basic Information List
Table GrayBug Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure GrayBug Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table Innocore Pharmaceuticals Basic Information List
Table Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales Growth Rate (2013-2018)
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Sales Global Market Share (2013-2018)
Figure Innocore Pharmaceuticals Sustained Release Ocular Drug Delivery Systems Revenue Global Market Share (2013-2018)
Table OHR Pharmaceuticals Basic Information List
Table PolyActiva Basic Information List
Table TheraKine Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sustained Release Ocular Drug Delivery Systems
Figure Manufacturing Process Analysis of Sustained Release Ocular Drug Delivery Systems
Figure Sustained Release Ocular Drug Delivery Systems Industrial Chain Analysis
Table Raw Materials Sources of Sustained Release Ocular Drug Delivery Systems Major Players in 2017
Table Major Buyers of Sustained Release Ocular Drug Delivery Systems
Table Distributors/Traders List
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share Forecast by Regions in 2025
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Regions in 2025
Figure United States Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure China Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Sustained Release Ocular Drug Delivery Systems Revenue and Growth Rate Forecast (2018-2025)
Figure Europe Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Sustained Release Ocular Drug Delivery Systems Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Sustained Release Ocular Drug Delivery Systems Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Revenue Market Share Forecast by Type (2018-2025)
Table Global Sustained Release Ocular Drug Delivery Systems Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Sustained Release Ocular Drug Delivery Systems Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Sustained Release Ocular Drug Delivery Systems Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【レポートのキーワード】

持続放出眼内薬物送達システム、リポソーム、マイクロカプセル/ナノカプセル、ミクロスフェア/ナノスフェア、インプラント、白内障、緑内障、角膜移植

【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[持続放出眼内薬物送達システムの世界市場2018] (Global Sustained Release Ocular Drug Delivery Systems Sales Market Report 2018 / QYR8056337)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆